Contec launches virtual training tool sensitive to social distancing
A web-based means of finding the cleaning products to meet the challenges posed by cleanroom operations.
The ongoing consequences of the novel coronavirus (COVID-19) now include the urgent call for social distancing (meeting postponement, limiting site visitors to facilities, etc.) Contec has, therefore, accelerated the launch of its online learning and training tool, VAL.
VAL (Virtual Assisted Learning) is a web-based means of allowing customer-partners to find the appropriate critical cleaning products to meet the challenges posed by their cleanroom operations by Grade/ISO Class. Moreover, each specific virtual 'environment' features numerous touch-points that highlight product solutions through clickable PDFs and videos which showcase best practice applications to clean and disinfect key equipment and/or surfaces.
“We understand and respect the steps our customers are taking to protect their employees and products,” says Matt Schiering, Chief Marketing Officer for Contec “Our digital and multimedia teams collaborated closely with product management and our customers to develop an educational portal that will assist users whether a rep is physically present or not. VAL works anywhere a customer wishes to access it – from home or work – on the device of their choice.”
VAL is more than a product selection tool; it also provides guidance, education and best practices to maintain the highest standards across a variety of critical cleaning environments. VAL covers more than two dozen touch-points, highlighting appropriate products for each specified area. VAL also features 25 distinct product recommendation PDFs, and provides 22 best-practice videos and eight custom illustrations for the US.
“The goal of VAL is to provide assistance to our customers whenever and wherever they need it,” shared Rick Harward, one of Contec’s cleanroom business managers. “In light of the current, evolving situation, we can’t be everywhere we’d like to be. But now, our service and expertise can be present even if we can’t be. Our entire salesforce will be available for any questions or to walk someone through VAL.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.